Lamelleye vs Comparator for the Treatment of Dry Eye Disease

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

August 9, 2017

Study Completion Date

August 9, 2017

Conditions
Dry Eye Syndromes
Interventions
DEVICE

Lamelleye Dry Eye Drops

Liposomal multi-dose preservative-free sterile suspension which contains soy lecithin phospholipids, sphingomyelin and cholesterol, suspended in saline.

DEVICE

Optive Plus

Multi-dose sterile solution which contains sodium carboxymethylcellulose, glycerine, Castor Oil, Polysorbate 80, levocarnitine, and erythritol, preserved with PURITE® which breaks down into natural tear components in the eye

Trial Locations (1)

G4 0BA

Glasgow Caledonian University, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lamellar Biomedical Ltd

INDUSTRY

collaborator

University of Glasgow

OTHER

lead

Glasgow Caledonian University

OTHER